The USA supports the statement by Canada on scheduling reviews of substances.
The USA second point relates to the CND 2014. We thank your proposal to further informal consultations on the agenda and the process. We want to ask how the Secretariat will support the modalities in the lead up of the special session, and how we design this. We should also take into account what the General Assembly has to say on this, so we need to see what happens both in Vienna and New York.